WeChat Mini Program
Old Version Features

Cost-effectiveness of Toripalimab Plus Chemotherapy Versus Chemotherapy As First-Line Treatment for Advanced Non-Small Cell Lung Cancer in China: a Societal Perspective

Dai Lian,Yi Yang,Yuling Gan,Dunming Xiao,Yuliang Xiang,Shan Jiang,Yuanyuan Gu,Yingyao Chen

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH（2025）

Cited 0|Views2
Key words
Toripalimab,non-small cell lung cancer,cost-effectiveness,societal perspective,China
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined